HF
BMY icon

HRT Financial’s Bristol-Myers Squibb BMY Stock Holding History

HRT Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-62,200
Closed -$3.66M – 1906
2020
Q2 		$3.66M Buy
62,200
+40,100
+181% +$2.4M 0.11% 181
2020
Q1 		$1.23M Buy
+22,100
New +$1.35M 0.08% 221

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HRT Financial's BMY Position: Q2 2026 in Review

HRT Financial reduced its Bristol-Myers Squibb (BMY) stake by 64% in Q2 2026, selling an estimated $76.6M and leaving 741,187 shares worth $42.7M. The position accounts for 0.08% of the portfolio, ranked #239.

HRT Financial first reported a position in BMY in Q4 2014 and has held it in 17 quarters since. The position peaked at $126M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • HRT Financial held 741,187 shares of Bristol-Myers Squibb worth $42.7M as of Q2 2026.
  • HRT Financial sold 1,334,758 Bristol-Myers Squibb shares in Q2 2026, an estimated $76.6M.
  • Bristol-Myers Squibb made up 0.08% of HRT Financial's portfolio in Q2 2026, its #239 holding.
  • HRT Financial first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 17 quarters since.
  • HRT Financial's Bristol-Myers Squibb position peaked at $126M in Q1 2026.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.